Women’s participation in breast cancer screening in France – an ethical approach

BMC Medical Ethics 15 (1):64 (2014)
  Copy   BIBTEX

Abstract

Breast cancer is a major public health challenge. Organized mammography screening (OS) is considered one way to reduce breast cancer mortality. EU recommendations prone mass deployment of OS, and back in 2004, France introduced a national OS programme for women aged 50–74 years. However, in 2012, participation rate was still just 52.7%, well short of the targeted 70% objective. In an effort to re-address the (in) efficiency of the programme, the French National Cancer Institute has drafted an expert-group review of the ethical issues surrounding breast cancer mammography screening

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 90,593

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Breast cancer incidence: what do the figures mean?Ann Johnson & Jane Shekhdar - 2005 - Journal of Evaluation in Clinical Practice 11 (1):27-31.
Breast cancer screening in younger women: evidence and decision making.J. Mark Elwood - 1997 - Journal of Evaluation in Clinical Practice 3 (3):179-186.
Breast cancer genetic screening and critical bioethics' gaze.Lisa S. Parker - 1995 - Journal of Medicine and Philosophy 20 (3):313-337.

Analytics

Added to PP
2014-08-16

Downloads
15 (#809,217)

6 months
6 (#202,901)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Principles of biomedical ethics.Tom L. Beauchamp - 1979 - New York: Oxford University Press. Edited by James F. Childress.

Add more references